GDTC
NASDAQ
$0.95
CytoMed Therapeutics Ltd (GDTC)
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company is headquartered in Singapore.
Sector:
Healthcare
Industry:
Biotechnology
Target: $5 (+426.32%)
Market Cap
$11M
Free Cash Flow Yield
-43.37%
Beta (5Y)
0.57
Price Chart
Valuation
Market Cap$11M
P/S14.02
P/B2.39
Profitability
Total Revenue (TTM)$500K
Gross Profit (TTM)$600K
EBITDA-$4.10M
Operating Margin-535%
EPS-$0.32
Financial Health
Debt-to-Equity7.4%
Free Cash Flow Yield-43.37%
Growth & Risk
Beta (5Y)0.57
Sharpe Ratio-0.46